Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to AbbVie
Related studies linked through entity extraction aliases.
BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment
- Status
- COMPLETED
- Phase
- PHASE3
Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation
- Status
- COMPLETED
- Phase
- N/A
Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China
- Status
- COMPLETED
- Phase
- N/A
An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Duvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K Inhibitor
- Status
- WITHDRAWN
- Phase
- PHASE1
Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection
- Status
- COMPLETED
- Phase
- PHASE3
A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection
- Status
- COMPLETED
- Phase
- PHASE3
Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary
- Status
- COMPLETED
- Phase
- N/A
The Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4)
- Status
- COMPLETED
- Phase
- PHASE3
Adalimumab in Alleviating Inflammation in Patients With Axial Spondyloarthritis
- Status
- UNKNOWN
- Phase
- PHASE4
Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P
- Status
- COMPLETED
- Phase
- PHASE3
Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis
- Status
- COMPLETED
- Phase
- PHASE3
Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1
- Status
- COMPLETED
- Phase
- N/A
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab
- Status
- COMPLETED
- Phase
- N/A